StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Humalog (insulin lispro) by Quarter

Humalog (insulin lispro) — Outside U.S. revenue ($M) [legacy] ($M)

QuarterlyAnnual

Eli Lilly Humalog (insulin lispro): $214M in Q4 2024, up 7.6% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2024
214
Period ended Dec 31, 2024
Change on a year earlier
+7.6%
199 in Q4 2023
History
32 quarters
Since Q1 2017
Sources
27
Documents cited below

Where the Q4 2024 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2025-02-19) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedHumalog (insulin lispro) — Outside U.S. revenue ($M) [legacy] ($M)Year on yearSource
Q4 2024Dec 31, 2024214+7.6%Form 10-K (filed 2025-02-19) ↗
Q3 2024Sep 30, 2024211+4.8%Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024197-6.5%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024200+5.9%Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 2023199-6.3%Form 10-K (filed 2025-02-19) ↗
Q3 2023Sep 30, 2023201+1.2%Form 10-Q (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023211+1.1%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023189-24.1%Form 10-Q (filed 2024-04-30) ↗
Q4 2022Dec 31, 2022212-26.8%Form 10-K (filed 2025-02-19) ↗
Q3 2022Sep 30, 2022199-28.8%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022208-25.2%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022249-12.3%Form 10-Q (filed 2023-04-27) ↗
Q4 2021Dec 31, 2021290-4.3%Form 10-K (filed 2024-02-21) ↗
Q3 2021Sep 30, 2021279+4.7%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021279+1.9%Form 10-Q (filed 2022-08-04) ↗
Q1 2021Mar 31, 2021284-4.3%Form 10-Q (filed 2022-04-29) ↗

Cite this data

StockData. (2026). Eli Lilly Humalog (insulin lispro) ($M), quarterly Q1 2017–Q4 2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-humalog-nonus

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.